3 active not recruiting, 2 recruiting, 1 completed. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Active not recruiting 3, Recruiting 2, Completed 1 |
Follow B Acute Lymphoblastic Leukemia: new trials by email Literature Review of B Acute Lymphoblastic Leukemia trials Research Report on B Acute Lymphoblastic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma Biospecimen Collection, Calaspargase Pegol, Levocarnitine - B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Phase 3 | Active not recruiting | Children's Oncology Group | 440 | 2023-08-24 | 2026-08-21 |
| Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration - B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma | Phase 3 | Recruiting | Children's Oncology Group | 5951 | 2019-10-31 | 2026-08-25 |
| A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia Asparaginase Erwinia chrysanthemi, Blinatumomab, Cyclophosphamide - B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 6720 | 2019-07-03 | 2026-11-12 |
| Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia Allopurinol, Cytarabine, Daunorubicin Hydrochloride - B Acute Lymphoblastic Leukemia | Phase 3 | Recruiting | Alliance for Clinical Trials in Oncology | 303 | 2017-09-20 | 2026-11-03 |
| Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Allogeneic Hematopoietic Stem Cell Transplantation, Calaspargase Pegol, Cyclophosphamide - Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia | Phase 3 | Active not recruiting | Children's Oncology Group | 352 | 2017-08-08 | 2026-10-05 |
| Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations Clofarabine, Cyclophosphamide, Cytarabine - B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like | Phase 3 | Completed | National Cancer Institute (NCI) | 5949 | 2012-02-29 | 2026-06-02 |
Burkitt Lymphoma (6) · Leukemia, Biphenotypic, Acute (3) · Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (2) · Down Syndrome (1)
DNA Virus Infections (6) · Epstein-Barr Virus Infections (6) · Hemic and Lymphatic Diseases (6) · Herpesviridae Infections (6) · Immune System Diseases (6) · Immunoproliferative Disorders (6) · Infections (6) · Lymphatic Diseases (6) · Lymphoma (6) · Lymphoma, B-Cell (6) · Lymphoma, Non-Hodgkin (6) · Lymphoproliferative Disorders (6) · Neoplasms (6) · Neoplasms by Histologic Type (6) · Tumor Virus Infections (6)
pegaspargase (6) · Cyclophosphamide (5) · Cytarabine (5) · Dexamethasone (5) · Doxorubicin (5) · Mercaptopurine (5) · Methotrexate (5) · Thioguanine (5) · Vincristine (5) · Asparaginase (4) · Calcium Dobesilate (4) · Daunorubicin (4) · Leucovorin (4) · auricularum (4) · azathiopurine (4)
Children's Oncology Group (3) · National Cancer Institute (NCI) (2) · Alliance for Clinical Trials in Oncology (1)
Canada (6) · United States (6) · Australia (4) · New Zealand (4) · Puerto Rico (4) · Switzerland (2) · Austria (1) · Belgium (1) · Chile (1) · Czechia (1) · Finland (1) · France (1) · Germany (1) · Hong Kong (1) · Ireland (1)
Andrea Biondi (1) · Etan Orgel (1) · Jennifer L McNeer (1) · Lewis B Silverman (1) · Michael J Burke (1) · Sumit Gupta (1)
PMID 41671463, PMID 32496902, PMID 32589970, PMID 33844429, PMID 37890117, PMID 39121442, PMID 39651791
U10CA180886 (4), 2017 (1), U10CA098543 (1), U10CA180821 (1), U24CA196173 (1), UG1CA189955 (1)